Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIAID

Strategies For Development Of Preventative And Therapeutic Interventions For Avian Influenza Infection In Human

  • Read more about Strategies For Development Of Preventative And Therapeutic Interventions For Avian Influenza Infection In Human
US Application 60/921,669
Filed on 2007-04-02

Gram Positive Three-Component Antimicrobial Peptide-Sensing System

  • Read more about Gram Positive Three-Component Antimicrobial Peptide-Sensing System
US Application 60/930,709
Filed on 2007-05-18

Monoclonal Antibody Against Dengur and Other Viruses with Deletion FC Region

  • Read more about Monoclonal Antibody Against Dengur and Other Viruses with Deletion FC Region
US Application 60/927,755
Filed on 2007-05-04

Use of Antagonists of the Interaction Between HIV Gp120 And Intregrin

  • Read more about Use of Antagonists of the Interaction Between HIV Gp120 And Intregrin
US Application 60/957,140
Filed on 2007-08-21

Ribosomal Protein S3 (RPS3) Is A Novel Critical Functional Component Of NK-KB P65 Binding Complexes For Certain Responsive Genes

  • Read more about Ribosomal Protein S3 (RPS3) Is A Novel Critical Functional Component Of NK-KB P65 Binding Complexes For Certain Responsive Genes
US Application 60/913,336
Filed on 2007-04-23

Collagen-platelet Aggregation Inhibitor From Mosquito Salivary Glands

  • Read more about Collagen-platelet Aggregation Inhibitor From Mosquito Salivary Glands
US Application 60/198,629
Filed on 2007-07-09

Pseudocoelomic Fluid From Ascaris Serum Protects From Allergic Diseases

  • Read more about Pseudocoelomic Fluid From Ascaris Serum Protects From Allergic Diseases
US Application 60/924,537
Filed on 2007-05-18

Structure of HIV Gp120-CCR5 N-Terminus and Its Use

  • Read more about Structure of HIV Gp120-CCR5 N-Terminus and Its Use
US Application 60/923,498
Filed on 2007-04-13

Adaptive Mutations That Increase The Infectivity Of Hepatitis C Virus JFJ1 In Cell Culture

  • Read more about Adaptive Mutations That Increase The Infectivity Of Hepatitis C Virus JFJ1 In Cell Culture
US Application 60/931,259
Filed on 2007-05-21

Antagonists Of The Direct Interaction Between HIV Gp120 And Intregrin

  • Read more about Antagonists Of The Direct Interaction Between HIV Gp120 And Intregrin
US Application 60/920,880
Filed on 2007-03-30

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 83
  • Page 84
  • Page 85
  • Page 86
  • Page 87
  • Page 88
  • Page 89
  • Page 90
  • Page 91
  • …
  • Next page ››
  • Last page Last »
Subscribe to NIAID
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health